In patients with severe AS who undergoing TAVI, elevated HE4 serum levels before the procedure are robustly associated with diffuse myocardial fibrosis and higher risk of treatment futility and adverse clinical events following the procedure. The gene discussed is WFDC2; the disease is aortic stenosis.